Letrozol Tarbis Farma (Letrozole)

Letrozole works by selectively blocking the aromatase enzyme, which converts androgens into estrogens in peripheral tissues. By reducing estrogen levels, the drug deprives estrogen‑dependent breast cancer cells of a key growth signal, thereby inhibiting tumor proliferation and promoting cell death.

The dose of letrozole is determined by the prescribing physician based on the patient’s clinical condition, treatment setting and other individual factors. The prescriber will select the appropriate strength and dosing schedule; patients should follow the exact instructions provided on the prescription label.

Letrozole is classified as contraindicated during pregnancy because it can interfere with fetal development by lowering estrogen levels. Safety data for breastfeeding are insufficient, and the drug may pass into breast milk. Women who are pregnant, planning to become pregnant, or nursing should not use letrozole.

To order Letrozol Tarbis Farma, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Letrozole belongs to the aromatase inhibitor class, similar to anastrozole and exemestane. Compared with anastrozole, letrozole generally provides a slightly stronger suppression of estrogen levels, which may translate into marginally better disease control in some patients. Choice of agent depends on physician preference, patient tolerance and specific clinical factors.

Letrozol Tarbis Farma tablets should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Letrozol Tarbis Farma is taken orally, usually as a whole tablet swallowed with water. It is typically taken once daily, at the same time each day, with or without food, unless the prescribing physician provides different instructions.

Serious risks associated with letrozole include cardiovascular events such as heart attack or stroke, severe liver toxicity manifested by elevated liver enzymes or hepatitis, and rare allergic reactions like anaphylaxis. Patients should promptly report chest pain, sudden weakness, jaundice, or signs of severe allergic response to their healthcare provider.

Letrozole should not be used by women who are pregnant or may become pregnant, as it can harm fetal development. It is also contraindicated in patients with known hypersensitivity to letrozole or any component of the formulation, and in those with severe liver impairment where the drug’s metabolism could be compromised.